TransBioLine | Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
01-02-2019
-31-01-2025
01-02-2019
-31-01-2025
01-01-2021
-31-12-2024
01-01-2019
-31-12-2024
01-01-2019
-31-12-2024
01-03-2023
-28-02-2027
01-01-2022
-31-12-2025
01-01-2020
-31-03-2024
01-05-2020
-30-04-2025
01-01-2017
-31-12-2024
01-10-2019
-31-03-2026
01-10-2017
-30-09-2021
01-10-2020
-30-09-2025
01-11-2021
-30-04-2024
01-06-2022
-30-11-2025
01-09-2023
-31-08-2027
01-04-2016
-30-09-2019
01-07-2021
-30-06-2025
01-11-2018
-31-10-2024
01-09-2024
-31-08-2029
01-11-2021
-31-10-2026
01-03-2019
-30-09-2022
01-01-2017
-30-09-2022
01-09-2017
-31-08-2023
01-02-2024
-31-01-2028
01-01-2021
-31-03-2025
01-03-2019
-28-02-2023
01-11-2017
-30-04-2021
01-05-2023
-30-04-2027
01-05-2018
-31-10-2022
01-09-2018
-30-06-2020